Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,751.00
Bid: 1,750.50
Ask: 1,751.50
Change: -24.00 (-1.35%)
Spread: 1.00 (0.057%)
Open: 1,770.00
High: 1,770.00
Low: 1,750.00
Prev. Close: 1,775.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Stocks at one-month high as Vodafone, RBS gain

Fri, 21st Feb 2014 08:47

- Vodafone, RBS and Glaxo provide a lift- IHG, Glencore Xstrata hit by downgrades- FTSE 100 at highest intraday level in monthtechMARK 2,891.98 +0.55%FTSE 100 6,840.31 +0.40%FTSE 250 16,419.58 +0.31% Strong gains from heavyweights Vodafone, RBS and GlaxoSmithKline gave UK markets a boost on Friday with stocks rising to levels not seen in a month.The FTSE 100 was trading 0.4% higher at 6,840 early on, its highest intraday level since January 22nd.A decent performance on Wall Street last night has helped to spur buying this morning, as US indices turned around after a poor start as data showed that manufacturing activity Stateside rose to a four-year high."I think this clearly highlights the fact that the market is still generally bullish and is once again looking for any excuse to buy," said Market Analyst Craig Erlam from Alpari.After a data-heavy week, today's session is set to be a little quieter on the macro front, though UK retail sales and public-sector borrowing figures will catch investors' attentions this morning.Vodafone, RBS and Glaxo provide a liftTelecoms titan Vodafone was making decent gains this morning with shareholders set to receive a windfall from the company's sale of its 45% stake in Verizon Wireless. The $130bn cash and shares deal is set to complete today.RBS was higher amid reports that the bank will announce plans to slash as many as 30,000 jobs, reducing its staff count to the lowest levels in more than 10 years.Pharmaceuticals giant GlaxoSmithKline was higher after European regulators recommended marketing authorisation for umeclidinium, its once-daily treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease.Millennium & Copthorne, the FTSE 250 hotel firm, jumped after reporting record revenues and profits for 2013 as fourth-quarter results were boosted by the one-off sale of the bulk of the Glyndebourne development in Singapore.Sector peer InterContinental Hotels Group, however, was trading in the red after Credit Suisse lowered its recommendation to 'underperform', pointing out that the shares are trading within just 4% of their all-time high at a price-to-earnings ratio of 23.Glencore Xstrata was also lower after JPMorgan Cazenove downgraded its rating on the stock to 'neutral', saying that its peers have overtaken it in terms of capital returns potential.FTSE 100 - RisersVodafone Group (VOD) 236.00p +2.79%Royal Bank of Scotland Group (RBS) 361.70p +1.69%ARM Holdings (ARM) 962.50p +1.64%Persimmon (PSN) 1,459.00p +1.53%Prudential (PRU) 1,370.00p +1.11%Barclays (BARC) 258.05p +1.10%Aviva (AV.) 473.40p +1.09%BAE Systems (BA.) 404.70p +1.07%British Land Co (BLND) 702.50p +0.93%Compass Group (CPG) 925.50p +0.93%FTSE 100 - FallersGlencore Xstrata (GLEN) 333.05p -2.17%InterContinental Hotels Group (IHG) 1,934.00p -2.08%Smiths Group (SMIN) 1,366.00p -1.73%IMI (IMI) 1,544.00p -1.34%Mondi (MNDI) 1,032.00p -1.24%Anglo American (AAL) 1,536.50p -1.13%Morrison (Wm) Supermarkets (MRW) 239.50p -1.07%Fresnillo (FRES) 975.00p -1.02%easyJet (EZJ) 1,732.00p -0.92%Antofagasta (ANTO) 942.50p -0.84%FTSE 250 - RisersMillennium & Copthorne Hotels (MLC) 598.00p +4.64%Essentra (ESNT) 875.00p +3.55%IP Group (IPO) 221.00p +3.22%Petra Diamonds Ltd.(DI) (PDL) 170.10p +3.03%Centamin (DI) (CEY) 51.70p +2.48%Morgan Advanced Materials (MGAM) 341.40p +1.88%Laird (LRD) 328.30p +1.77%Informa (INF) 531.00p +1.72%Afren (AFR) 156.10p +1.63%AL Noor Hospitals Group (ANH) 917.50p +1.61%FTSE 250 - FallersVesuvius (VSVS) 462.70p -1.91%Telecity Group (TCY) 669.50p -1.69%Electra Private Equity (ELTA) 2,439.00p -1.45%Dechra Pharmaceuticals (DPH) 675.50p -1.39%Xaar (XAR) 1,095.00p -1.35%Evraz (EVR) 82.10p -1.20%Crest Nicholson Holdings (CRST) 375.00p -1.19%Debenhams (DEB) 74.25p -0.93%UK Commercial Property Trust (UKCM) 78.00p -0.83%Domino's Pizza Group (DOM) 543.50p -0.82%BC
More News
13 Feb 2024 09:32

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
13 Feb 2024 07:45

LONDON BRIEFING: "Record" Tui quarter; Ultimate Products eyes payouts

(Alliance News) - London's FTSE 100 is to open ever-so-slightly lower on Tuesday, with trade set to be nervy ahead of the afternoon's US inflation data.

Read more
12 Feb 2024 17:11

London close: Stocks finish higher after very quiet Monday

(Sharecast News) - London markets managed modest gains by the close of a subdued trading session on Monday, with no significant corporate or economic catalysts driving movements.

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.